Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells
Previously, we reported that lysophosphatidylethanolamine (LPE), a lyso-type metabolite of phosphatidylethanolamine, can increase intracellular Ca2+ ([Ca2+]i) via type 1 lysophosphatidic acid (LPA) receptor (LPA1) and CD97, an adhesion G-protein-coupled receptor (GPCR), in MDA-MB-231 breast cancer c...
Main Authors: | Park, Soo-Jin, Lee, Kyoung-Pil, Im, Dong-Soon |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Society of Applied Pharmacology
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975480/ |
Similar Items
-
Anti-Cancer Effect of IN-2001 in MDA-MB-231 Human Breast Cancer
by: Min, Kyung Nan, et al.
Published: (2012) -
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
by: Xie, Jing, et al.
Published: (2016) -
Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells
by: Spina, Annamaria, et al.
Published: (2013) -
Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells
by: Annamaria Spina, et al.
Published: (2013-02-01) -
Effects of combination therapy of docetaxel with selenium on the human breast cancer cell lines MDA-MB-231 and MCF-7
by: Park, Sang O, et al.
Published: (2015)